Latest Trading Halts News

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

Antilles Gold Limited has had its trading suspension lifted on the ASX following the release of its quarterly activity and cash flow reports for June 2025, reopening the stock to market activity.

Xanadu Mines Ltd shares will be suspended from ASX trading following compulsory acquisition notices issued by Bastion Mining Pte. Ltd, signaling a significant shift in ownership.

Dragon Mountain Gold Limited has responded to an ASX price query following a sharp share price increase, denying any undisclosed information and confirming compliance with continuous disclosure rules.

Syrah Resources has successfully completed a A$42 million institutional placement and entitlement offer, with a fully underwritten retail offer set to raise a further A$28 million, bolstering its capital for key operations.

Nagambie Resources reported a challenging quarter with negative operating cash flow but bolstered its liquidity through a $3 million secured loan and an ongoing share placement.

Nagambie Resources has reported a significant assay result from its newly discovered C4 antimony-gold lode, reinforcing its structural model and advancing plans for a joint venture gold treatment plant amid a fresh capital raise.

Pacific Nickel Mines continues mining activities at its Kolosori Nickel Project under Glencore financing despite ongoing ASX suspension and operational challenges.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Forrestania Resources has voluntarily suspended trading on the ASX as it prepares to announce a significant acquisition, signaling a potentially transformative move for the mining company.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.

FinTech Chain Limited has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift for the fintech company.